News & Alerts
-
Sep- 2023 -27 September
Intercept Pharma Accepts Alfasigma’s $800 million Buyout Offer After FDA Rejections for NASH Therapy
Following two FDA rejections for its non-alcoholic steatohepatitis (NASH) therapy, obeticholic acid (OCA), Intercept Pharma has accepted a takeover offer…
Read More » -
27 September
Pfizer Restarts Production Plant in North Carolina Following Tornado Damage in July
By Cara Murez HealthDay Reporter A Pfizer plant that makes vital drugs, anesthesia and hospital supplies has restarted production after…
Read More » -
27 September
Novo Nordisk Invests $60 Million in Valo Health for AI-Powered Drug Discovery
Novo Nordisk, the Danish pharmaceutical company, has invested $60 million in a collaboration with Valo Health, a US-based startup, to…
Read More » -
27 September
Takeda Expands Neuroscience Portfolio with PIKfyve-Targeting Drug Candidates for ALS
Takeda has expanded its neuroscience research portfolio through a licensing agreement with the California biotech firm AcuraStem. This strategic partnership…
Read More » -
27 September
AscellaHealth Honored For Exceptional Contribution to Rare Disease Funding
AscellaHealth has been honored with an industry award for its innovative financial solution designed to address the affordability challenges associated…
Read More » -
26 September
Roche Avastin: Investigation Launched As 12 Patients Go Blind After Receiving The Cancer Drug
Health authorities in Pakistan have initiated an investigation into two local distributors responsible for handling Swiss pharmaceutical company Roche’s Avastin…
Read More » -
26 September
FDA Unanimously Rejects Implantable Type 2 Diabetes Drug Delivery Product, Citing Risk-Benefit Imbalance
An FDA panel delivered a unanimous 19-0 vote, marking its third consecutive refusal to approve ITCA 650, an innovative experimental…
Read More » -
26 September
Diligent Robotics to Expand Moxi System with $25 Million Funding
Diligent Robotics, a company that specializes in robotic systems, is set to significantly expand its Moxi robot system across the…
Read More » -
26 September
CMS Cites Two California Hospitals Over Medication Errors, Prompting Corrective Actions
In a recent report by the Los Angeles Times, it has been revealed that the Centers for Medicare and Medicaid…
Read More » -
25 September
VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1g/10mL Due to Microbial Contamination Identified as Bacillus Cereus
Audience: Health Professional, Pharmacy, Consumer Largo, Florida, VistaPharm LLC is voluntarily recalling one (1) lot of Sucralfate Oral Suspension, 1g/10mL,…
Read More »